ANEB
Anebulo Pharmaceuticals
ANEB
ANEB
Delisted
ANEB was delisted on the 27th of February, 2026.
14 hedge funds and large institutions have $18.6M invested in Anebulo Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
14% less capital invested
Capital invested by funds: $21.6M → $18.6M (-$2.98M)
Holders
14
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.88M | |
| 2 | +$706K | |
| 3 | +$307K | |
| 4 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
+$35.3K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$54 |
Top Sellers
| 1 | -$1.22M | |
| 2 | -$542K | |
| 3 | -$68.9K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$27.6K |
| 5 |
BlackRock
New York
|
-$113 |